CN105963527A - Traditional Chinese medicine extracting solution capable of quickly healing wound and preparation method thereof - Google Patents
Traditional Chinese medicine extracting solution capable of quickly healing wound and preparation method thereof Download PDFInfo
- Publication number
- CN105963527A CN105963527A CN201610405399.0A CN201610405399A CN105963527A CN 105963527 A CN105963527 A CN 105963527A CN 201610405399 A CN201610405399 A CN 201610405399A CN 105963527 A CN105963527 A CN 105963527A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- radix
- rhizoma
- wound healing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 102
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 208000027418 Wounds and injury Diseases 0.000 title abstract description 22
- 206010052428 Wound Diseases 0.000 title abstract description 18
- 230000035876 healing Effects 0.000 title abstract description 5
- 230000029663 wound healing Effects 0.000 claims abstract description 29
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 12
- 239000004863 Frankincense Substances 0.000 claims abstract description 11
- 239000007788 liquid Substances 0.000 claims description 38
- 238000000605 extraction Methods 0.000 claims description 22
- 238000000855 fermentation Methods 0.000 claims description 22
- 230000004151 fermentation Effects 0.000 claims description 22
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000009286 sanguis draxonis Substances 0.000 claims description 14
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 13
- 241001057584 Myrrha Species 0.000 claims description 11
- 241000717739 Boswellia sacra Species 0.000 claims description 10
- 239000000706 filtrate Substances 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 239000000047 product Substances 0.000 claims description 5
- 238000002791 soaking Methods 0.000 claims description 5
- 241001468229 Bifidobacterium thermophilum Species 0.000 claims description 4
- 241000186012 Bifidobacterium breve Species 0.000 claims description 3
- 241001608472 Bifidobacterium longum Species 0.000 claims description 3
- 229940009291 bifidobacterium longum Drugs 0.000 claims description 3
- 239000006041 probiotic Substances 0.000 claims description 2
- 235000018291 probiotics Nutrition 0.000 claims description 2
- 210000000481 breast Anatomy 0.000 claims 1
- 239000002304 perfume Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 22
- 230000008901 benefit Effects 0.000 abstract description 3
- 239000004615 ingredient Substances 0.000 abstract description 2
- 231100000419 toxicity Toxicity 0.000 abstract description 2
- 230000001988 toxicity Effects 0.000 abstract description 2
- 235000008216 herbs Nutrition 0.000 abstract 4
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 240000007311 Commiphora myrrha Species 0.000 abstract 1
- 235000006965 Commiphora myrrha Nutrition 0.000 abstract 1
- 235000007265 Myrrhis odorata Nutrition 0.000 abstract 1
- 240000004824 Trimezia steyermarkii Species 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 239000009136 dragon's blood Substances 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 230000006378 damage Effects 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 7
- 210000002950 fibroblast Anatomy 0.000 description 7
- 208000014674 injury Diseases 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 208000015181 infectious disease Diseases 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 230000000857 drug effect Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 208000032843 Hemorrhage Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- 102000013275 Somatomedins Human genes 0.000 description 3
- 239000004480 active ingredient Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 229940126678 chinese medicines Drugs 0.000 description 3
- 238000005469 granulation Methods 0.000 description 3
- 230000003179 granulation Effects 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000003387 muscular Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000008733 trauma Effects 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010000269 abscess Diseases 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000004663 cell proliferation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 210000004177 elastic tissue Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- CPKVUHPKYQGHMW-UHFFFAOYSA-N 1-ethenylpyrrolidin-2-one;molecular iodine Chemical compound II.C=CN1CCCC1=O CPKVUHPKYQGHMW-UHFFFAOYSA-N 0.000 description 1
- 206010002515 Animal bite Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000013883 Blast injury Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000018380 Chemical injury Diseases 0.000 description 1
- 208000009084 Cold Injury Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 206010018276 Gingival bleeding Diseases 0.000 description 1
- 208000024283 Gingival haemorrhages Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 108060003393 Granulin Proteins 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 229920000153 Povidone-iodine Polymers 0.000 description 1
- 208000019155 Radiation injury Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000004520 agglutination Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000589 cicatrix Anatomy 0.000 description 1
- 230000002595 cold damage Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000009707 neogenesis Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 229960001621 povidone-iodine Drugs 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000007838 tissue remodeling Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/58—Meliaceae (Chinaberry or Mahogany family), e.g. Azadirachta (neem)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to quick wound healing medicine, in particular to a traditional Chinese medicine extracting solution capable of quickly healing a wound and a preparation method thereof. The traditional Chinese medicine extracting solution is prepared from radix angelica sinensis, radix sanguisorbae, radix lithospermi, radix et rhizoma rhei, coptidis rhizomes, cortex phellodendri, rhizoma polygoni cuspidate, frankincense, diverse wormwood herb, rhizoma bletillae, radix angelicae dahuricae, myrrh, cortex meliae, borneol and dragon's blood. Compared with the prior art, the traditional Chinese medicine extracting solution has the advantages that all the Chinese herbs cooperate with one another through scientific compatibility to achieve the highest herbal efficacy; meanwhile, the ingredients of the Chinese herbs are effectively extracted through the unique preparation method to fully achieve the herbal efficacy of the Chinese herbs; in addition, little toxicity and few side effects of the Chinese herbs can be effectively removed by adopting the extracting solution mode, and then the purpose of quickly healing the wound is achieved.
Description
Technical field
The present invention relates to wound healing medicine, particularly relate to a kind of wound healing Chinese medicine extraction liquid and preparation method thereof.
Background technology
In the daily life of the mankind, the mankind are often as be not intended to or other situations cause phenomenon that wound occur, therefore, from ancient times to the present, skin trauma, damage are all surgical clinical commonly encountered diseases, and such as burn and scald, various wound, skin ulcer, mucosa injury etc. broadly fall into surgical wound, as cured not in time, pathogenic factor and antibacterial invade, not only can expand wound surface, skin ulceration, even cause infection, produce septicemia, cause death.Repair in trauma is one of study hotspot in surgical field all the time.Wound healing is the pathological process caused after wound, is jointly to be participated in by multiple somatomedin, cytokine, inflammatory cell and repair cell, the complicated and process of hight coordinate.Wound is complicated, and influence factor is numerous, except fibroblast, inflammatory cell, somatomedin, Fn Fiberonectin trace element, pH value etc., also extracellular matrix, epidermis cell and cytokine profiles.
Modern medicine is thought, the agglutination of wound surface is generally divided into local inflammation reaction, cell proliferation and differentiation and Reconstruction 3 the most different stage overlapping again.These 3 any one links of stage are affected, and all may cause the prolongation of wound healing time, therefore, effectively control local infection, promote cell proliferation, increase collage synthesis and wound surface nutrition, become the acceleration effective method of wound healing.
Specifically, skin wound healing is the repair process after skin histology sustains damage, and repair process includes that inflammatory reaction, hyperplasia and cambium are reinvented.Inflammatory reaction includes various cytokine, leukocyte etc.；Cell neogenesis includes the autologous propagation of fibroblast or mesenchymal cell is divided into fibroblast etc.；Tissue remodeling includes the skin histology being rearranged into certain function in order of fibroblast.Thus, fibroblast is the host cell composition in dermis of skin, and it has together constituted with the main body of corium with collagen fiber, elastic fiber and the matrix components self secreted.The major function of fibroblast is: synthesize and secrete collagen fiber, elastic fiber, Matrix protein material and some somatomedin, the elasticity and toughness maintaining skin is had important function, and the minimizing of fibroblast is also the major reason causing wrinkle to produce.
But Shortcomings in conventional wound medicine.Such as disinfectant (povidone iodine etc.), the use of adhesive bandage, sterilizing effect can be played, but trauma pain can not be reduced；External lidocaine emulsifiable paste and aerosol, can play analgesic effect, but it is poor to control infection；Other is with Chinese medicine extract as principal agent, is mostly medical mechanical domain, and quality control standard is the strictest；It mostly is ointment, liniment in topical drug dosage form, is administered and there is inconvenience.
Summary of the invention
The present invention is directed to the deficiency of pure existence in above-mentioned traditional wound medicine, propose wound healing Chinese medicine extraction liquid that a kind of formula is reasonable, simple for production, wound healing fast, healed and preparation method thereof.
In order to achieve the above object, the technical solution used in the present invention is, the present invention provides a kind of wound healing Chinese medicine extraction liquid, it is characterized in that, including following active princlple: Radix Angelicae Sinensis, Radix Sanguisorbae, Radix Arnebiae (Radix Lithospermi), Radix Et Rhizoma Rhei, Rhizoma Coptidis, Cortex Phellodendri, Rhizoma Polygoni Cuspidati, Olibanum, Herba Artemisiae Anomalae, Pseudobulbus Bletillae (Rhizoma Bletillae), the Radix Angelicae Dahuricae, Myrrha, Cortex Meliae, Borneolum Syntheticum, Sanguis Draxonis.
As preferably, include following active princlple according to parts by weight: Radix Angelicae Sinensis 5 parts～10 parts, Radix Sanguisorbae 10 parts～20 parts, Radix Arnebiae (Radix Lithospermi) 5 parts～10 parts, Radix Et Rhizoma Rhei 5 parts～10 parts, Rhizoma Coptidis 7 parts～15 parts, Cortex Phellodendri 5 parts～10 parts, Rhizoma Polygoni Cuspidati 3 parts～8 parts, Olibanum 5 parts～10 parts, Herba Artemisiae Anomalae 5 parts～10 parts, Pseudobulbus Bletillae (Rhizoma Bletillae) 5 parts～10 parts, the Radix Angelicae Dahuricae 5 parts～10 parts, Myrrha 7 parts～15 parts, Cortex Meliae 5 parts～10 parts, Borneolum Syntheticum 2 parts～8 parts, Sanguis Draxonis 5 parts～10 parts.
It is further preferred that include following active princlple according to parts by weight: Radix Angelicae Sinensis 10 parts, Radix Sanguisorbae 20 parts, Radix Arnebiae (Radix Lithospermi) 10 parts, Radix Et Rhizoma Rhei 10 parts, Rhizoma Coptidis 8 parts, Cortex Phellodendri 10 parts, Rhizoma Polygoni Cuspidati 5 parts, Olibanum 8 parts, Herba Artemisiae Anomalae 10 parts, Pseudobulbus Bletillae (Rhizoma Bletillae) 7 parts, the Radix Angelicae Dahuricae 8 parts, Myrrha 7 parts, Cortex Meliae 5 parts, Borneolum Syntheticum 6 parts, Sanguis Draxonis 10 parts.
Present invention also offers the method preparing above-mentioned wound healing Chinese medicine extraction liquid, comprise the following steps:
A, by ready Chinese medicine component in boiling water rapid soaking filter under, pull out the most rapidly, drain；
B, will drain after Chinese medicine cutting become unqualified shape, in being then placed in pot, dry pot stir-fries；
C, will stir-fry after Chinese medicine put in pot, add water, slow fire boils 1 hour；
D, after liquid medicine cooling in pot, Chinese medicine and liquid medicine are put into fermentation tank, add strain, ferment；
E, after fermentation completes, take out the Chinese medicine that ferments and liquid medicine, filter, obtain filtrate；
F, carrying out high temperature compressed by filtrate, being compressed to relative concentration is 1.5～1.7, i.e. obtains finished product.
As preferably, in described step c, amount of water is 2～3 times of Chinese medicine gross weight.
As preferably, in described Step d, strain is the mixture of yeast and bacillus bifidus, amount is Chinese medicine gross weight 1%～the 4% of described interpolation strain.
As preferably, the mass ratio of described yeast and bacillus bifidus is 1:1.5.
As preferably, described bacillus bifidus is at least one probiotics in bifidobacterium longum, bifidobacterium breve, avette bacillus bifidus, bifidobacterium thermophilum.
As preferably, in described Step d, controlling fermentation temperature 24 DEG C～28 DEG C in fermentation tank, fermentation time is 28～48 hours.
Compared with prior art, advantages of the present invention and good effect are,
1, the present invention is by providing a kind of Chinese medicine extraction liquid, utilize the compatibility of science, make between each Chinese medicine the most collaborative, play maximum drug effect, simultaneously, utilize unique preparation method, effectively the composition of Chinese medicine is extracted, give full play to the drug effect of Chinese medicine, and, use the mode of extracting solution, it is also possible to the effective removal micro-toxicity of Chinese medicine and little side effect, and then reach the purpose of rapid healing wound.
Detailed description of the invention
In order to be more clearly understood that the above-mentioned purpose of the present invention, feature and advantage, below in conjunction with embodiment, the present invention will be further described.It should be noted that in the case of not conflicting, the feature in embodiments herein and embodiment can be mutually combined.
Elaborate a lot of detail in the following description so that fully understanding the present invention, but, the present invention can be different from other modes described here with employing and implement, and therefore, the present invention is not limited to the restriction of the specific embodiment of description described below.
Embodiment 1, the present embodiment provides a kind of wound healing Chinese medicine extraction liquid, including following active princlple: Radix Angelicae Sinensis 5 parts, Radix Sanguisorbae 10 parts, Radix Arnebiae (Radix Lithospermi) 5 parts, Radix Et Rhizoma Rhei 5 parts, Rhizoma Coptidis 7 parts, Cortex Phellodendri 5 parts, Rhizoma Polygoni Cuspidati 3 parts, Olibanum 5 parts, Herba Artemisiae Anomalae 5 parts, Pseudobulbus Bletillae (Rhizoma Bletillae) 5 parts, the Radix Angelicae Dahuricae 5 parts, Myrrha 7 parts, Cortex Meliae 5 parts, Borneolum Syntheticum 2 parts, Sanguis Draxonis 5 parts.
In above-mentioned formula, Radix Angelicae Sinensis has enriches blood；Invigorate blood circulation；Menstruction regulating and pain relieving；Moisturize effect of laxation, it is possible to enrich blood, invigorate blood circulation, and there is antibacterial, arteriosclerosis effect；Radix Sanguisorbae has cooling blood for hemostasis, heat-clearing and toxic substances removing, effect of detumescence sore；Radix Arnebiae (Radix Lithospermi), has removing heat from blood, invigorates blood circulation, effect of removing toxic substances rash；Radix Et Rhizoma Rhei has effect of blood circulation promoting and blood stasis dispelling；Rhizoma Coptidis has a heat clearing and damp drying, eliminating fire and detoxication, more can and Radix Et Rhizoma Rhei between more preferable compatibility, improve effect；Cortex Phellodendri, has effect of heat-clearing and toxic substances removing, heat clearing and damp drying；Rhizoma Polygoni Cuspidati has effect of heat-clearing and toxic substances removing, and has treatment burn due to hot liquid or fire, injury from falling down, the effect of carbuncle sore tumefacting virus；Olibanum has more significant analgesic activity, and can have more intensive bacteriostasis；Herba Artemisiae Anomalae has the effect of hemostasis of curing the wound；Pseudobulbus Bletillae (Rhizoma Bletillae) has astringing to arrest bleeding, effect of detumescence and promoting granulation；The Radix Angelicae Dahuricae has evacuation of pus of invigorating blood circulation, effect of granulation promoting pain relieving；Myrrha has the effect such as promoting blood circulation and stopping pain, detumescence and promoting granulation；Cortex Meliae has effect of heat clearing away；Borneolum Syntheticum has effect of reducing swelling and alleviating pain；Sanguis Draxonis has blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, astringing to arrest bleeding, the remarkable efficacy such as hard masses softening and resolving, promoting tissue regeneration and ulcer healing, by above-mentioned Chinese medicinal ingredients, with Sanguis Draxonis, Herba Artemisiae Anomalae, Radix Sanguisorbae, Radix Et Rhizoma Rhei as monarch drug, it is equipped with Radix Arnebiae (Radix Lithospermi), Rhizoma Coptidis, the Radix Angelicae Dahuricae, Myrrha, Radix Angelicae Sinensis, Pseudobulbus Bletillae (Rhizoma Bletillae) are ministerial drug, finally it is equipped with the medicines such as Cortex Phellodendri, Rhizoma Polygoni Cuspidati, Olibanum, Borneolum Syntheticum, reaching the purpose of wound healing, and eliminate in wound healing process, some of generation are uncomfortable, such as, the symptom such as infection, pain.
nullWhen specifically preparing，First，By ready Chinese medicine component in boiling water rapid soaking filter under，Pull out the most rapidly，Drain，Quickly immersed with being beneficial to kill the antibacterial on some surfaces，And do not affect the drug effect of Chinese medicine，After Chinese medicine drains，Chinese medicine cutting is become unqualified shape，Put into the dry pot of pot to stir-fry，The purpose that dry pot stir-fries is Radix Angelicae Sinensis、Sanguis Draxonis、The active ingredient of the Chinese medicines such as Cortex Phellodendri is in the sweat in later stage，Preferably decompose out，Improve the effect of herb fermenting，After the time that stir-fries has the temperature of 30～40 DEG C with medicine，Stopping stir-fries，After waiting to stir-fry，After stir-frying, Chinese medicinal powder is put in pot，Add water，Amount of water is 2～3 times of Chinese medicine gross weight，Then slow fire boils 1 hour，After having boiled，After liquid medicine cooling in pot，Chinese medicine and the liquid medicine that boils are put into fermentation tank，Add strain，The addition of strain is the 1%～4% of Chinese medicine gross weight，In the present embodiment，It is 1%，Strain is preferably the mixture of yeast and bacillus bifidus，Can certainly be single yeast or bacillus bifidus，In the present embodiment，The mass ratio of yeast and bacillus bifidus is 1:1.5，Specifically，Bifidus bacillus is the mixed bacteria of bifidobacterium longum and bifidobacterium breve，Then seal，Then temperature 24 DEG C～28 DEG C in fermentation tank is controlled，Fermentation time is to ferment for 36 hours；After fermentation completes, take out the Chinese medicine and liquid medicine fermented, filter, obtain filtrate；Then, carrying out high temperature compressed by filtrate, being compressed to relative concentration is 1.5～1.7, i.e. obtains finished product.
Embodiment 2, the present embodiment provides a kind of wound healing Chinese medicine extraction liquid, including following active princlple: Radix Angelicae Sinensis 10 parts, Radix Sanguisorbae 20 parts, Radix Arnebiae (Radix Lithospermi) 10 parts, Radix Et Rhizoma Rhei 10 parts, Rhizoma Coptidis 15 parts, Cortex Phellodendri 10 parts, Rhizoma Polygoni Cuspidati 8 parts, Olibanum 10 parts, Herba Artemisiae Anomalae 10 parts, Pseudobulbus Bletillae (Rhizoma Bletillae) 10 parts, the Radix Angelicae Dahuricae 10 parts, Myrrha 15 parts, Cortex Meliae 10 parts, Borneolum Syntheticum 8 parts, Sanguis Draxonis 10 parts.
nullWhen specifically preparing，First，By ready Chinese medicine component in boiling water rapid soaking filter under，Pull out the most rapidly，Drain，Quickly immersed with being beneficial to kill the antibacterial on some surfaces，And do not affect the drug effect of Chinese medicine，After Chinese medicine drains，Chinese medicine cutting is become unqualified shape，Put into the dry pot of pot to stir-fry，The purpose that dry pot stir-fries is Radix Angelicae Sinensis、Sanguis Draxonis、The active ingredient of the Chinese medicines such as Cortex Phellodendri is in the sweat in later stage，Preferably decompose out，Improve the effect of herb fermenting，After the time that stir-fries has the temperature of 30～40 DEG C with medicine，Stopping stir-fries，After waiting to stir-fry，After stir-frying, Chinese medicinal powder is put in pot，Add water，Amount of water is 2～3 times of Chinese medicine gross weight，Then slow fire boils 1 hour，After having boiled，After liquid medicine cooling in pot，Chinese medicine and the liquid medicine that boils are put into fermentation tank，Add strain，The addition of strain is the 1%～4% of Chinese medicine gross weight，In the present embodiment，It is 3%，Strain is preferably the mixture of yeast and bacillus bifidus，Can certainly be single yeast or bacillus bifidus，In the present embodiment，The mass ratio of yeast and bacillus bifidus is 1:1.5，Specifically，Bifidus bacillus is the mixed bacteria of avette bacillus bifidus and bifidobacterium thermophilum，Then seal，Then temperature 24 DEG C～28 DEG C in fermentation tank is controlled，Fermentation time is to ferment for 28 hours；After fermentation completes, take out the Chinese medicine and liquid medicine fermented, filter, obtain filtrate；Then, carrying out high temperature compressed by filtrate, being compressed to relative concentration is 1.5～1.7, i.e. obtains finished product.
Embodiment 3, the present embodiment provides a kind of wound healing Chinese medicine extraction liquid, including following active princlple: Radix Angelicae Sinensis 10 parts, Radix Sanguisorbae 20 parts, Radix Arnebiae (Radix Lithospermi) 10 parts, Radix Et Rhizoma Rhei 10 parts, Rhizoma Coptidis 8 parts, Cortex Phellodendri 10 parts, Rhizoma Polygoni Cuspidati 5 parts, Olibanum 8 parts, Herba Artemisiae Anomalae 10 parts, Pseudobulbus Bletillae (Rhizoma Bletillae) 7 parts, the Radix Angelicae Dahuricae 8 parts, Myrrha 7 parts, Cortex Meliae 5 parts, Borneolum Syntheticum 6 parts, Sanguis Draxonis 10 parts.
nullWhen specifically preparing，First，By ready Chinese medicine component in boiling water rapid soaking filter under，Pull out the most rapidly，Drain，Quickly immersed with being beneficial to kill the antibacterial on some surfaces，And do not affect the drug effect of Chinese medicine，After Chinese medicine drains，Chinese medicine cutting is become unqualified shape，Put into the dry pot of pot to stir-fry，The purpose that dry pot stir-fries is Radix Angelicae Sinensis、Sanguis Draxonis、The active ingredient of the Chinese medicines such as Cortex Phellodendri is in the sweat in later stage，Preferably decompose out，Improve the effect of herb fermenting，After the time that stir-fries has the temperature of 30～40 DEG C with medicine，Stopping stir-fries，After waiting to stir-fry，After stir-frying, Chinese medicinal powder is put in pot，Add water，Amount of water is 2～3 times of Chinese medicine gross weight，Then slow fire boils 1 hour，After having boiled，After liquid medicine cooling in pot，Chinese medicine and the liquid medicine that boils are put into fermentation tank，Add strain，The addition of strain is the 1%～4% of Chinese medicine gross weight，In the present embodiment，It is 4%，Strain is preferably the mixture of yeast and bacillus bifidus，Can certainly be single yeast or bacillus bifidus，In the present embodiment，The mass ratio of yeast and bacillus bifidus is 1:1.5，Specifically，Bifidus bacillus is the mixed bacteria of avette bacillus bifidus and bifidobacterium thermophilum，Then seal，Then temperature 24 DEG C～28 DEG C in fermentation tank is controlled，Fermentation time is to ferment for 48 hours；After fermentation completes, take out the Chinese medicine and liquid medicine fermented, filter, obtain filtrate；Then, carrying out high temperature compressed by filtrate, being compressed to relative concentration is 1.5～1.7, i.e. obtains finished product.
Toxicity test
Taking ICR mice, before experiment, water 15h is can't help in fasting, is divided into 19 groups (the trial drug group of each embodiment 6 groups, matched groups 1 group).Each group mouse tail vein is administered, and tests 1 group and is the most according to dosage respectively 500mg/kg, 1000mg/kg, 2000mg/kg, 5000mg/kg, 10000mg/kg, 20000mg/kg to 6 groups of dosages of test, and control group mice gives same volume distilled water.Examine and record and be administered the toxic reaction and death condition at once occurred to mice in 7d；Bliss ' s method is used to calculate LD50.The following form of experimental result:
| Group | mg/Kg |
| Embodiment 1 group | 5970.6mg/Kg |
| Embodiment 2 group | 6078.4mg/Kg |
| Embodiment 3 group | 6540.8mg/Kg |
The LD50 of medicine is at more than 5970mg/kg as seen from the above table, it is clear that the toxicity of this medicine is the lowest, in rational range, few to the toxic and side effects of human body.
Chinese medicine extraction liquid prepared by the embodiment of the present invention may be used for the wound for the treatment of and includes: the infection of injury of human, human body thin T bacterium, skin and the hemorrhage oozing of blood of muscular tissue.Wherein injury of human includes: scratch, sword device hurts, are stabbed, blast injury (damage that shock wave causes), burn, cold injury, animal bite, chemical injury, radiation injury and above-mentioned in the damage etc. that causes of two or more combination；Human body antibacterial sense includes: epidermis or muscular tissue abscess, rotten, ulcer etc.；Skin and the hemorrhage oozing of blood of muscular tissue include: gingival hemorrhage, epistaxis etc..Using method is: daily 2～3 times, a 100ml, it is also possible to smear use.
Clinical case:
Case 1 patient female, 61 years old, careless incised wound left hand thumb palmar when cutting the dish, straight cut, injures muscle, at once pain, bleed, treatment of distal thumb can not bend, use the present invention provide Chinese medicine extraction liquid, take and be applied in wound surface in right amount, wrapping, and according to dosage take extracting solution, within three days, change a medicine, wound healing after 1 week.
Case 2 patient man, 40 years old, femoribus internus intramuscular infection produced abscess, rear incision and drainage, smear in drainage strip the present invention offer Chinese medicine extraction liquid, in right amount, wrapping, and according to dosage take extracting solution, within three days, change a medicine, wound healing after first quarter moon.
Case 3 patient female, 12 years old, hand was scalded, and used the Chinese medicine extraction liquid of the present invention, takes appropriate painting and is spread on scald wound, and after one hour, pain eliminates, and according to dosage took extracting solution, and every day 2～smear a medicine, wound healing after 4 weeks for 3 times, did not had cicatrix.
The above; it it is only presently preferred embodiments of the present invention; it it is not the restriction that the present invention is made other form; any those skilled in the art are changed possibly also with the technology contents of the disclosure above or are modified as the Equivalent embodiments of equivalent variations is applied to other field; but it is every without departing from technical solution of the present invention content; any simple modification, equivalent variations and the remodeling made above example according to the technical spirit of the present invention, still falls within the protection domain of technical solution of the present invention.
Claims (9)
1. a wound healing Chinese medicine extraction liquid, it is characterised in that include following active princlple: Radix Angelicae Sinensis,
Radix Sanguisorbae, Radix Arnebiae (Radix Lithospermi), Radix Et Rhizoma Rhei, Rhizoma Coptidis, Cortex Phellodendri, Rhizoma Polygoni Cuspidati, Olibanum, Herba Artemisiae Anomalae, Pseudobulbus Bletillae (Rhizoma Bletillae), the Radix Angelicae Dahuricae, Myrrha,
Cortex Meliae, Borneolum Syntheticum, Sanguis Draxonis.
Wound healing Chinese medicine extraction liquid the most according to claim 1, it is characterised in that according to weight
Amount number includes following active princlple: Radix Angelicae Sinensis 5 parts～10 parts, Radix Sanguisorbae 10 parts～20 parts, Radix Arnebiae (Radix Lithospermi) 5 parts～10
Part, Radix Et Rhizoma Rhei 5 parts～10 parts, Rhizoma Coptidis 7 parts～15 parts, Cortex Phellodendri 5 parts～10 parts, Rhizoma Polygoni Cuspidati 3 parts～8 parts, breast
Perfume 5 parts～10 parts, Herba Artemisiae Anomalae 5 parts～10 parts, Pseudobulbus Bletillae (Rhizoma Bletillae) 5 parts～10 parts, the Radix Angelicae Dahuricae 5 parts～10 parts, Myrrha 7
Part～15 parts, Cortex Meliae 5 parts～10 parts, Borneolum Syntheticum 2 parts～8 parts, Sanguis Draxonis 5 parts～10 parts.
Wound healing Chinese medicine extraction liquid the most according to claim 2, it is characterised in that according to weight
Amount number includes following active princlple: Radix Angelicae Sinensis 10 parts, Radix Sanguisorbae 20 parts, Radix Arnebiae (Radix Lithospermi) 10 parts, Radix Et Rhizoma Rhei 10 parts,
Rhizoma Coptidis 8 parts, Cortex Phellodendri 10 parts, Rhizoma Polygoni Cuspidati 5 parts, Olibanum 8 parts, Herba Artemisiae Anomalae 10 parts, Pseudobulbus Bletillae (Rhizoma Bletillae) 7 parts, the Radix Angelicae Dahuricae
8 parts, Myrrha 7 parts, Cortex Meliae 5 parts, Borneolum Syntheticum 6 parts, Sanguis Draxonis 10 parts.
4. the method preparing wound healing Chinese medicine extraction liquid described in above-mentioned 1～3 any one, its feature
It is, comprises the following steps:
A, by ready Chinese medicine component in boiling water rapid soaking filter under, pull out the most rapidly, drain；
B, will drain after Chinese medicine cutting become unqualified shape, in being then placed in pot, dry pot stir-fries；
C, will stir-fry after Chinese medicine put in pot, add water, slow fire boils 1 hour；
D, after liquid medicine cooling in pot, Chinese medicine and liquid medicine are put into fermentation tank, add strain, carry out sending out
Ferment；
E, after fermentation completes, take out the Chinese medicine that ferments and liquid medicine, filter, obtain filtrate；
F, carrying out high temperature compressed by filtrate, being compressed to relative concentration is 1.5～1.7, i.e. obtains finished product.
The preparation method of wound healing Chinese medicine extraction liquid the most according to claim 4, its feature exists
In, in described step c, amount of water is 2～3 times of Chinese medicine gross weight.
The preparation method of wound healing Chinese medicine extraction liquid the most according to claim 4, its feature exists
In, in described Step d, strain is the mixture of yeast and bacillus bifidus, and the amount of described interpolation strain is
The 1%～4% of Chinese medicine gross weight.
The preparation method of wound healing Chinese medicine extraction liquid the most according to claim 6, its feature exists
In, the mass ratio of described yeast and bacillus bifidus is 1:1.5.
The preparation method of wound healing Chinese medicine extraction liquid the most according to claim 7, its feature exists
In, described bacillus bifidus is bifidobacterium longum, bifidobacterium breve, avette bacillus bifidus, bifidobacterium thermophilum
In at least one probiotics.
The preparation method of wound healing Chinese medicine extraction liquid the most according to claim 4, its feature exists
In, in described Step d, controlling fermentation temperature 24 DEG C～28 DEG C in fermentation tank, fermentation time is 28～48 little
Time.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610405399.0A CN105963527A (en) | 2016-06-07 | 2016-06-07 | Traditional Chinese medicine extracting solution capable of quickly healing wound and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610405399.0A CN105963527A (en) | 2016-06-07 | 2016-06-07 | Traditional Chinese medicine extracting solution capable of quickly healing wound and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105963527A true CN105963527A (en) | 2016-09-28 |
Family
ID=57010906
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610405399.0A Pending CN105963527A (en) | 2016-06-07 | 2016-06-07 | Traditional Chinese medicine extracting solution capable of quickly healing wound and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105963527A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108992581A (en) * | 2018-09-29 | 2018-12-14 | 湖南省善恩祥药业有限公司 | A kind of traditional Chinese medicinal ointment and preparation method thereof for treating skin lesion |
| CN111789915A (en) * | 2020-08-31 | 2020-10-20 | 吴荣东 | External Chinese herbal medicine powder dressing for diabetic foot and preparation method thereof |
| CN114767786A (en) * | 2022-05-13 | 2022-07-22 | 中南民族大学 | External skin-generating oil for preventing and treating liquid nitrogen ultralow-temperature frostbite and preparation method and application thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102895526A (en) * | 2012-10-31 | 2013-01-30 | 唐和斌 | Externally-applied skin-generating oil for treatment of burn and preparation method and application thereof |
| CN103565921A (en) * | 2013-11-04 | 2014-02-12 | 王立发 | Specific medicine for treating bedsore and promoting quick healing of wound |
| CN103830506A (en) * | 2014-01-24 | 2014-06-04 | 河南科技大学第一附属医院 | Composite ointment used for rapid wound heal and preparation method thereof |
| CN105267450A (en) * | 2015-12-02 | 2016-01-27 | 白帅军 | Traditional Chinese medicine composition for repairing trauma wound surfaces |
-
2016
- 2016-06-07 CN CN201610405399.0A patent/CN105963527A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102895526A (en) * | 2012-10-31 | 2013-01-30 | 唐和斌 | Externally-applied skin-generating oil for treatment of burn and preparation method and application thereof |
| CN103565921A (en) * | 2013-11-04 | 2014-02-12 | 王立发 | Specific medicine for treating bedsore and promoting quick healing of wound |
| CN103830506A (en) * | 2014-01-24 | 2014-06-04 | 河南科技大学第一附属医院 | Composite ointment used for rapid wound heal and preparation method thereof |
| CN105267450A (en) * | 2015-12-02 | 2016-01-27 | 白帅军 | Traditional Chinese medicine composition for repairing trauma wound surfaces |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108992581A (en) * | 2018-09-29 | 2018-12-14 | 湖南省善恩祥药业有限公司 | A kind of traditional Chinese medicinal ointment and preparation method thereof for treating skin lesion |
| CN111789915A (en) * | 2020-08-31 | 2020-10-20 | 吴荣东 | External Chinese herbal medicine powder dressing for diabetic foot and preparation method thereof |
| CN114767786A (en) * | 2022-05-13 | 2022-07-22 | 中南民族大学 | External skin-generating oil for preventing and treating liquid nitrogen ultralow-temperature frostbite and preparation method and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11571452B2 (en) | Method of treating a skin wound with a liquid-state topical pharmaceutical composition | |
| CN103230493B (en) | Traditional Chinese medicine composition for treating unhealed wound | |
| CN102125634A (en) | Chinese medicinal composition for treating bedsore | |
| CN106728727A (en) | It is a kind of to treat ointment of sore and preparation method thereof | |
| CN105250696A (en) | Traditional Chinese medicine gel capable of promoting skin wound to heal and preparation method of traditional Chinese medicine gel | |
| CN105963527A (en) | Traditional Chinese medicine extracting solution capable of quickly healing wound and preparation method thereof | |
| CN103656092A (en) | Ointment for treating trauma and preparation method thereof | |
| CN105168361A (en) | Compound plant oil liniment for treating burns and scalds and preparation method of compound plant oil liniment | |
| CN101401890B (en) | External use medicament capable of effectively treating wound surface infection | |
| CN102727698B (en) | Wound surface nursing powder for treating bedsore | |
| CN108721442B (en) | Traditional Chinese medicine composition and preparation for treating burns, scalds and diaper dermatitis and preparation method thereof | |
| CN103263496B (en) | Medicinal composition for treating burn | |
| CN101036712A (en) | Scald and burn ointment | |
| CN113197973A (en) | Pharmaceutical composition and preparation method thereof | |
| CN104800427A (en) | Burn and scald recovery application and preparation method thereof | |
| CN111991471A (en) | A topical Chinese medicinal preparation for treating knife wound, burn and scald, and its preparation method | |
| CN105311473A (en) | Rapid hemostasis drug | |
| CN103721056A (en) | Pure Chinese herbal medicine oil agent for treating burn and scald | |
| CN103127274A (en) | All-season burn and scald medicine for seasons | |
| CN109045204A (en) | A kind of herb liquid and preparation method thereof for treating burn and scald | |
| CN108420877A (en) | It is a kind of to treat traumatic injury and swelling and pain relieving Chinese medicine preparation | |
| CN108066466A (en) | A kind of Chinese medicine composition for treating burn and scald and preparation method and application | |
| CN102920800A (en) | Topical drug composite and application and preparation method thereof | |
| CN103394009B (en) | Traditional Chinese medicine for treating trauma and diabetes foot ulcer and preparation method | |
| CN107714781B (en) | Pharmaceutical composition for treating burns and scalds and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160928 |